drugset / Trial / NCT03806777
Intra-nasal Dexmedetomidine for Children Undergoing MRI Imaging
Phase 4
Unknown
180 enrolled
University of British Columbia
British Columbia Children's Hospital · collab
NaSingle-groupOpen-labelHealth-services research
Summary
This study aims to assess the use of intranasal dexmedetomidine (IN-dex) as a sole agent in aiding the successful completion of a MRI scans in children. Dexmedetomidine, a routinely used anesthetic agent in our institution, has many benefits including sedation with neuro-protective and respiratory sparing features. We will test its effectiveness in completing MRI scans in children that would otherwise be given a full general anesthetic.
Timeline
- Start
- 2019-02
- Primary completion
- 2020-03
- Completion
- 2020-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 1 ug/kg | Intranasal |
| Subject | Dexmedetomidine | Other / unclassified | 4 ug/kg | Intranasal |
| Subject | Dexmedetomidine | Other / unclassified | 200 ug | Intranasal |
Indications
No indication recorded.